The role of adjuvant zoledronic acid in locally advanced prostate cancer
The role of adjuvant zoledronic acid in locally advanced prostate cancer
批准号:
nhmrc : 1099149
负责人:
Prof David Joseph
金额:
$25.61万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 2017-12-31
中文摘要
该项目寻求确认雷达前列腺癌试验中非常令人鼓舞的早期发现,以便测试的新疗法能够进入临床实践。这项试验涉及澳新银行23个癌症治疗中心的1071名男性,他们在前列腺中出现了广泛的癌症肿块,但没有扩散的证据。所有人都在2003年至2007年期间接受了试验治疗。该项目涉及收集和分析截至2017年9月的后续信息。
英文摘要
This project seeks to confirm the highly encouraging early findings from the RADAR prostate cancer trial so that the new treatments tested can be brought in to clinical practice. The trial involved 1071 men at 23 cancer treatment centres in ANZ who had developed extensive cancerous masses in their prostates but without evidence of spread. All received their trial treatments between 2003 and 2007. This project involves the collection and analysis of follow up information up until September 2017.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Value of androgen deprivation and bisphosphonate therapy in patients treated by radiotherapy for limited prostate cancer
-
批准号:nhmrc : 300705
-
项目类别:NHMRC Project Grants
-
资助金额:$117.18万
-
财政年份:2004
-
负责人:Prof David Joseph
-
依托单位:
海外基金